- Home
- UAN vs CDXC Comparison
UAN vs CDXC Comparison
Compare UAN & CDXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UAN
- CDXC
- Stock Information
- Founded
- UAN 2007
- CDXC 1999
- Country
- UAN United States
- CDXC United States
- Employees
- UAN N/A
- CDXC N/A
- Industry
- UAN Agricultural Chemicals
- CDXC Medicinal Chemicals and Botanical Products
- Sector
- UAN Industrials
- CDXC Health Care
- Exchange
- UAN Nasdaq
- CDXC Nasdaq
- Market Cap
- UAN 710.0M
- CDXC 572.6M
- IPO Year
- UAN 2011
- CDXC N/A
- Fundamental
- Price
- UAN $75.60
- CDXC $5.99
- Analyst Decision
- UAN
- CDXC Strong Buy
- Analyst Count
- UAN 0
- CDXC 2
- Target Price
- UAN N/A
- CDXC $8.00
- AVG Volume (30 Days)
- UAN 44.4K
- CDXC 732.2K
- Earning Date
- UAN 10-28-2024
- CDXC 10-31-2024
- Dividend Yield
- UAN 8.89%
- CDXC N/A
- EPS Growth
- UAN N/A
- CDXC N/A
- EPS
- UAN 4.97
- CDXC 0.02
- Revenue
- UAN $527,388,000.00
- CDXC $91,668,000.00
- Revenue This Year
- UAN N/A
- CDXC $18.64
- Revenue Next Year
- UAN N/A
- CDXC $20.72
- P/E Ratio
- UAN $15.09
- CDXC $301.89
- Revenue Growth
- UAN N/A
- CDXC 9.95
- 52 Week Low
- UAN $61.62
- CDXC $1.36
- 52 Week High
- UAN $88.94
- CDXC $7.97
- Technical
- Relative Strength Index (RSI)
- UAN 53.84
- CDXC 40.09
- Support Level
- UAN $74.25
- CDXC $5.87
- Resistance Level
- UAN $77.62
- CDXC $7.79
- Average True Range (ATR)
- UAN 2.18
- CDXC 0.34
- MACD
- UAN -0.49
- CDXC -0.24
- Stochastic Oscillator
- UAN 15.51
- CDXC 6.67
About UAN CVR Partners LP Common Units representing Limited Partner Interests
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.
About CDXC ChromaDex Corporation
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.